These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1751953)

  • 1. A new approach to adoptive immunotherapy of cancer using tumorcytotoxic macrophages grown from peripheral blood monocytes.
    Andreesen R; Scheibenbogen C; Brugger W; Krause S; Leser HG; Kopf S; Engler H; Schümichen C; Löhr GW
    Cancer Detect Prev; 1991; 15(5):413-21. PubMed ID: 1751953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy.
    Andreesen R; Scheibenbogen C; Brugger W; Krause S; Meerpohl HG; Leser HG; Engler H; Löhr GW
    Cancer Res; 1990 Dec; 50(23):7450-6. PubMed ID: 1701343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale production of human tumorcytotoxic macrophages grown from blood monocytes of cancer patients.
    Brugger W; Scheibenbogen C; Krause S; Andreesen R
    Cancer Detect Prev; 1991; 15(5):407-12. PubMed ID: 1751952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.
    Hahn G; Stuhlmüller B; Hain N; Kalden JR; Pfizenmaier K; Burmester GR
    J Clin Invest; 1993 Mar; 91(3):862-70. PubMed ID: 8450066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive immunotherapy of solid tumors with activated macrophages: experimental and clinical results.
    Bartholeyns J; Lopez M; Andreesen R
    Anticancer Res; 1991; 11(3):1201-4. PubMed ID: 1888150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
    Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
    Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyethylenimine-mediated transfection of human monocytes with the IFN-gamma gene: an approach for cancer adoptive immunotherapy.
    Ringenbach L; Bohbot A; Tiberghien P; Oberling F; Feugeas O
    Gene Ther; 1998 Nov; 5(11):1508-16. PubMed ID: 9930304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of LPS, IFN-gamma and TNF alpha on the secretion of lysozyme by individual human mononuclear phagocytes: relationship to cell maturity.
    Lewis CE; McCarthy SP; Lorenzen J; McGee JO
    Immunology; 1990 Mar; 69(3):402-8. PubMed ID: 2107146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the dependence of human monocytes and macrophages antitumoral properties upon TNF-alpha expression or release.
    Dumont S; Mabondzo A; Hartmann D; Gilgenkrantz JL; Kessler R; Poindron P; Bartholeyns J
    Anticancer Res; 1990; 10(4):949-54. PubMed ID: 2116753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender dimorphism of macrophage response to GMCSF and IL-4 for differentiation into dendritic cells.
    Gupta V; Singh SM
    Am J Reprod Immunol; 2008 Jul; 60(1):43-54. PubMed ID: 18593437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment.
    Werner-Felmayer G; Werner ER; Fuchs D; Hausen A; Reibnegger G; Wachter H
    Cancer Res; 1990 May; 50(10):2863-7. PubMed ID: 2110500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
    Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
    Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.
    Chang AE; Yoshizawa H; Sakai K; Cameron MJ; Sondak VK; Shu S
    Cancer Res; 1993 Mar; 53(5):1043-50. PubMed ID: 8439951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective induction of mononuclear phagocytes to produce neopterin by interferons.
    Bitterlich G; Szabó G; Werner ER; Larcher C; Fuchs D; Hausen A; Reibnegger G; Schulz TF; Troppmair J; Wachter H
    Immunobiology; 1988 Feb; 176(3):228-35. PubMed ID: 2452128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive immunotherapy with activated macrophages grown in vitro from blood monocytes in cancer patients: a pilot study.
    Lopez M; Fechtenbaum J; David B; Martinache C; Chokri M; Canepa S; De Gramont A; Louvet C; Gorin I; Mortel O
    J Immunother (1991); 1992 Apr; 11(3):209-17. PubMed ID: 1515425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune control of neoplasia by adoptive transfer of macrophages: potentiality for antigen presentation and gene transfer.
    Bartholeyns J; Lopez M
    Anticancer Res; 1994; 14(6B):2673-6. PubMed ID: 7872699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
    van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
    Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between pretreatment serum levels of neopterin and response to interleukin-2 immunotherapy in cancer patients.
    Lissoni P; Barni S; Ardizzoia A; Scardino E; Tancini G; Viganò MG
    J Biol Regul Homeost Agents; 1995; 9(1):21-3. PubMed ID: 8553904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.